Regulation of γδ T cell survival by soluble HLA-I:: Involvement of CD8 and activating killer Ig-like receptors

被引:15
|
作者
Poggi, A
Contini, P
Catellani, S
Setti, M
Murdaca, G
Zocchi, MR
机构
[1] Ist Nazl Ric Canc, Lab Expt Oncol D, I-16132 Genoa, Italy
[2] Univ Genoa, Clin Immunol Lab, Genoa, Italy
[3] Ist Sci San Raffaele, Lab Tumor Immunol, I-20132 Milan, Italy
[4] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy
关键词
apoptosis soluble; HLA-I; gamma delta T cells; CD8; activating IRS;
D O I
10.1002/eji.200526177
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We show that human V delta 1 or V delta 2 T lymphocytes secrete FasL and undergo apoptosis upon incubation with soluble HLA (sHLA) -I or after cross-linking of CD8, with a kinetics different from that observed following ligation of TCR. sHLA-1-induced apoptosis was blocked by anti-CD8 mAb; on the other hand, sHLA-1 was not effective in CD8- clones, while an HLA-I mutated in the alpha 3 domain, responsible for CD8 binding, was not functional on CD8(+) clones. Purified sHLA-Cw3 or -Cw4 alleles, isolated from the Cw3- or Cw4-transfected 721.221 lymphoblastoid cell line, triggered gamma delta T cell apoptosis, interacting with the specific receptors CD158j/KIR2DS2 or CD158 h/KIR2DS1, respectively, also known as activating isoforms of killer Ig-like receptors (KIR). Again, this effect was dependent on FasL secretion and it was blocked by specific mAb to KIR2DS2 or KIR2DS1. The engagement of CD8 or activating KIR also triggered the production of TNF-alpha. Noteworthy, sHLA-I molecules synergize with antigen-mediated activation of V delta 2 T cells: Indeed, V delta 2 T lymphocytes produced TNF-a when stimulated with isopentenyl pyrophosphate, and this effect was enhanced by sHLA-I. These findings suggest that sHLA-I can regulate gamma delta T cell survival and that activating KIR may amplify antigen-specific V delta 2 T cell responses.
引用
收藏
页码:2670 / 2678
页数:9
相关论文
共 50 条
  • [21] Differential regulation of killer cell Ig-like receptors and CD94 lectin-like dimers on NK and T lymphocytes from HIV-1-infected individuals
    André, P
    Brunet, C
    Guia, S
    Gallais, H
    Sampol, J
    Vivier, E
    Dignat-George, F
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1999, 29 (04) : 1076 - 1085
  • [22] HLA-F and MHC Class I Open Conformers Are Ligands for NK Cell Ig-like Receptors
    Goodridge, Jodie P.
    Burian, Aura
    Lee, Ni
    Geraghty, Daniel E.
    JOURNAL OF IMMUNOLOGY, 2013, 191 (07): : 3553 - 3562
  • [23] Coevolution of Killer Cell Ig-Like Receptors with HLA-C To Become the Major Variable Regulators of Human NK Cells
    Aguilar, Anastazia M. Older
    Guethlein, Lisbeth A.
    Adams, Erin J.
    Abi-Rached, Laurent
    Moesta, Achim K.
    Parham, Peter
    JOURNAL OF IMMUNOLOGY, 2010, 185 (07): : 4238 - 4251
  • [24] Coordinated expression of ig-like inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8+ T cells
    Anfossi, N
    Doisne, JM
    Peyrat, MA
    Ugolini, S
    Bonnaud, O
    Bossy, D
    Pitard, V
    Merville, P
    Moreau, JF
    Delfraissy, JF
    Dechanet-Merville, J
    Bonneville, M
    Venet, A
    Vivier, E
    JOURNAL OF IMMUNOLOGY, 2004, 173 (12): : 7223 - 7229
  • [25] Functional Analysis of Killer Ig-Like Receptor-Expressing Cytomegalovirus-Specific CD8+ T Cells
    van der Veken, Lars T.
    Campelo, Maria Diez
    van der Hoorn, Menno A. W. G.
    Hagedoorn, Renate S.
    van Egmond, H. M. Esther
    van Bergen, Jeroen
    Willemze, Roel
    Falkenburg, J. H. Frederik
    Heemskerk, Mirjam H. M.
    JOURNAL OF IMMUNOLOGY, 2009, 182 (01): : 92 - 101
  • [26] Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells
    Cognet, Celine
    Farnarier, Catherine
    Gauthier, Laurent
    Frassati, Coralie
    Andre, Pascale
    Magerus-Chatinet, Aude
    Anfossi, Nicolas
    Rieux-Laucat, Frederic
    Vivier, Eric
    Schleinitz, Nicolas
    CLINICAL IMMUNOLOGY, 2010, 135 (01) : 26 - 32
  • [27] Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G
    Shiroishi, M
    Tsumoto, K
    Amano, K
    Shirakihara, Y
    Colonna, M
    Braud, VM
    Allan, DSJ
    Makadzange, A
    Rowland-Jones, S
    Willcox, B
    Jones, EY
    van der Merwe, PA
    Kumagai, I
    Maenaka, K
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (15) : 8856 - 8861
  • [28] HLA-I Associated Adaptation Dampens CD8 T-Cell Responses in HIV Ad5-Vectored Vaccine Recipients
    Boppana, Sushma
    Sterrett, Sarah
    Files, Jacob
    Qin, Kai
    Fiore-Gartland, Andrew
    Cohen, Kristen W.
    De Rosa, Stephen C.
    Bansal, Anju
    Goepfert, Paul A.
    JOURNAL OF INFECTIOUS DISEASES, 2019, 220 (10): : 1620 - 1628
  • [29] In vivo apoptosis of CD8+ lymphocytes in acute myeloid leukemia patients:: involvement of soluble HLA-I and Fas ligand
    Contini, P.
    Zocchi, M. R.
    Pierri, I.
    Albarello, A.
    Poggi, A.
    LEUKEMIA, 2007, 21 (02) : 253 - 260
  • [30] In vivo apoptosis of CD8+ lymphocytes in acute myeloid leukemia patients: involvement of soluble HLA-I and Fas ligand
    P Contini
    M R Zocchi
    I Pierri
    A Albarello
    A Poggi
    Leukemia, 2007, 21 : 253 - 260